Pfizer and BioNTech have asked the Food and Drug Administration for emergency use authorization for a COVID-19 vaccine for children ages 6 months to 4 years old.
This has been done at the request of the FDA, Pfizer said yesterday.
Pfizer and BioNTech have asked the Food and Drug Administration for emergency use authorization for a COVID-19 vaccine for children ages 6 months to 4 years old.
This has been done at the request of the FDA, Pfizer said yesterday.